{ 'indexed': {'date-parts': [[2023, 2, 2]], 'date-time': '2023-02-02T05:45:28Z', 'timestamp': 1675316728711},
'reference-count': 0,
'publisher': 'American Association for the Advancement of Science (AAAS)',
'content-domain': {'domain': [], 'crossmark-restriction': False},
'published-print': {'date-parts': [[2023, 2, 1]]},
'DOI': '10.1126/science.adg9677',
'type': 'dataset',
'created': {'date-parts': [[2023, 2, 1]], 'date-time': '2023-02-01T22:40:58Z', 'timestamp': 1675291258000},
'source': 'Crossref',
'is-referenced-by-count': 0,
'title': 'Could a popular COVID-19 antiviral supercharge the pandemic?',
'prefix': '10.1126',
'member': '221',
'container-title': 'AAAS Articles DO Group',
'original-title': [],
'deposited': { 'date-parts': [[2023, 2, 1]],
'date-time': '2023-02-01T22:40:59Z',
'timestamp': 1675291259000},
'score': 1,
'resource': { 'primary': { 'URL': 'https://www.science.org/content/article/could-popular-covid-19-antiviral-supercharge-pandemic'}},
'subtitle': [],
'short-title': [],
'issued': {'date-parts': [[2023, 2, 1]]},
'references-count': 0,
'URL': 'http://dx.doi.org/10.1126/science.adg9677',
'relation': {},
'published': {'date-parts': [[2023, 2, 1]]}}
